Tuberous sclerosis with two unusual findings: cutaneous rhabdomyoma and chronic myelogenous leukaemia

Clin Exp Dermatol. 2020 Aug;45(6):799-801. doi: 10.1111/ced.14187. Epub 2020 Feb 25.

Authors

T Bardawil¹, L El Jamal², O Abbas³, M Kurban^{1

4

5}

Affiliations

¹ Department of Dermatology, American University of Beirut, Beirut, Lebanon.
² American University of Beirut Medical School, Beirut, Lebanon.
³ Department of Dermatology and Dermatopathology, American University of Beirut, Beirut, Lebanon.
⁴ Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon.
⁵ Dermatology Unit, Keserwan Medical Center, Ghazir, Lebanon.

PMID: 32097503
DOI: 10.1111/ced.14187

No abstract available

Publication types

Case Reports

MeSH terms

Angiomyolipoma / diagnostic imaging
Brain / pathology
Brain Neoplasms / diagnostic imaging
Female
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / therapeutic use
Kidney Neoplasms / pathology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
Magnetic Resonance Imaging / methods
Multiple Pulmonary Nodules / diagnostic imaging
Multiple Pulmonary Nodules / pathology
Neoplasms, Multiple Primary / pathology
Rhabdomyoma / complications
Rhabdomyoma / diagnosis*
Sirolimus / administration & dosage
Sirolimus / therapeutic use
Skin Neoplasms / pathology*
Tomography, X-Ray Computed / methods
Tuberous Sclerosis / diagnosis*
Tuberous Sclerosis / drug therapy
Tuberous Sclerosis / genetics
Tuberous Sclerosis / pathology
Tuberous Sclerosis Complex 1 Protein / genetics
Tuberous Sclerosis Complex 2 Protein / genetics
Young Adult

Substances

Immunosuppressive Agents
TSC1 protein, human
TSC2 protein, human
Tuberous Sclerosis Complex 1 Protein
Tuberous Sclerosis Complex 2 Protein
Sirolimus